ArticleJournal of Crohn's & colitis2021

The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.

Marianne R Spalinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.